LncTarD: a manually-curated database of experimentally-supported functional lncRNA?target regulations in human diseases

Hongying Zhao, Jian Shi, Yunpeng Zhang, Aimin Xie, Lei Yu, Caiyu Zhang, Junjie Lei, Haotian Xu, Zhijun Leng, Tengyue Li, Waidong Huang, Shihua Lin, Li Wang, Yun Xiao, Xia LiNucleic Acids Res 2020 · DOI

TL;DR

Researchers have developed LncTarD, a comprehensive, manually curated database that links long non-coding RNAs (lncRNAs) to their specific target genes and the resulting biological functions in human diseases. This resource aims to fill a critical gap by providing experimentally validated information on lncRNA regulatory mechanisms, which is essential for developing new diagnostic and therapeutic strategies for diseases.

What Problem Does This Paper Address?

Long non-coding RNAs (lncRNAs) are a class of RNA molecules longer than 200 nucleotides that do not code for proteins. While their involvement in human diseases, particularly cancers, has garnered significant attention, a major challenge has been the lack of a centralized, curated repository for detailed information on their regulatory roles. Existing databases often focus on basic lncRNA annotation or predicted interactions, but they largely miss the crucial experimentally supported functional regulations, the specific downstream targets, and the precise biological functions that disease-associated lncRNAs influence. This gap hinders our understanding of disease pathogenesis and the identification of novel therapeutic targets. LncTarD aims to bridge this gap by providing a meticulously curated collection of experimentally validated lncRNA-target regulations in the context of human diseases.

Methods

The researchers employed a rigorous manual curation process to build LncTarD. They systematically searched the PubMed literature database using keywords related to lncRNAs and human diseases. Articles were selected based on specific criteria: they had to describe lncRNAs associated with human diseases, identify key target genes of these lncRNAs, and mention important biological functions affected by these interactions.

For each validated interaction, the database captures:

  • LncRNA and Target Gene Information: Names, coordinates, and identifiers.
  • Disease Association: Specific human diseases linked to the regulation.
  • Regulatory Mechanisms: How the lncRNA exerts its effect (e.g., ceRNA/sponge, transcriptional regulation, epigenetic regulation, protein interaction).
  • Functional Impact: The biological functions influenced by the regulation (e.g., cell proliferation, apoptosis, angiogenesis).
  • Experimental Evidence: Details of the experimental methods used to validate the interaction.
  • Expression Data: Information on lncRNA expression patterns (upregulated/downregulated) and associations with target gene expression.

Additionally, they integrated transcriptome data from The Cancer Genome Atlas (TCGA) pan-cancer cohort to analyze the dynamic expression correlations of these lncRNA-target regulations across various cancer types.

Datasets

  • PubMed Literature: The primary source for manual curation of experimentally supported lncRNA-target regulations in human diseases.
  • The Cancer Genome Atlas (TCGA) Pan-Cancer Cohort: Transcriptome data from approximately 11,000 patients across 33 cancer types were used to analyze differential gene expression and expression correlations.

Key Insights and Ideas

  • The Power of Manual Curation: The emphasis on manual curation ensures a high level of data quality and reliability, distinguishing LncTarD from databases relying solely on computational predictions. This is crucial for understanding complex biological mechanisms.
  • Disease-Specific vs. Common Regulations: A significant finding is that while some lncRNA-target regulations are specific to a single disease type (suggesting high specificity), a notable proportion of regulators and targets are implicated in multiple diseases. This hints at shared underlying mechanisms across different pathologies.
  • Functional Dynamics: Integrating TCGA data allows for the exploration of how lncRNA-target regulations behave dynamically within the complex landscape of cancer, providing a more nuanced understanding of their roles.
  • Drug Resistance/Sensitivity Link: LncTarD specifically highlights lncRNA-target regulations associated with drug resistance or sensitivity, opening avenues for developing targeted therapies to overcome treatment challenges.

Key Results

As of December 2018, LncTarD contains:

  • 2822 key lncRNA-target regulations.
  • These involve 475 lncRNAs and 1039 target genes.
  • Regulations are associated with 177 human diseases.
  • 1613 are experimentally supported functional regulations.
  • 1209 are expression associations.
  • 140 biological functions are covered.
  • The database includes information on 52 drugs related to drug resistance/sensitivity in 41 human diseases.

Top lncRNAs by number of associated regulations include MALAT1, HOTAIR, and H19. Top diseases include lung cancer, liver cancer, and gastric cancer.

Limitations and Future Work

  • Limitations: The paper acknowledges that the current version is based on data available up to December 2018. The dynamic nature of research means new findings are constantly emerging.
  • Future Work: The authors plan to:
  • Integrate more data on epigenetic modifications (histone modification, DNA methylation) and chromatin structure to understand lncRNA regulation at a deeper level.
  • Incorporate data on protein-RNA interactions (RIP-seq, CLIP-seq) to further elucidate lncRNA mechanisms.
  • Expand the database with multi-omics data from patients with various diseases to better understand disease progression.
  • Regularly update the database and add more annotation information and analytical tools.

The ultimate goal is to provide a continuously evolving resource that aids in understanding lncRNA deregulation in disease pathogenesis, facilitating the discovery of novel biomarkers and therapeutic targets.

Summary updated

BibTeX
@article{zhao2020lnctard,
  author = {Hongying Zhao and Jian Shi and Yunpeng Zhang and Aimin Xie and Lei Yu and Caiyu Zhang and Junjie Lei and Haotian Xu and Zhijun Leng and Tengyue Li and Waidong Huang and Shihua Lin and Li Wang and Yun Xiao and Xia Li},
  title = {{LncTarD: a manually-curated database of experimentally-supported functional lncRNA?target regulations in human diseases}},
  journal = {Nucleic Acids Res.},
  year = {2020},
  doi = {10.1093/nar/gkz985},
}
Figure